| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6071856 | Journal of the American Academy of Dermatology | 2014 | 11 Pages |
Abstract
PCFCL has an excellent 5-year overall survival (100% disease-specific survival). Chromosomal abnormalities of either BCL2 or MALT1 were detected in 10% of cases but do not correlate with a specific immune pathology or clinical outcome.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Alya BSc, MBBS, MRCP, Soo-Yong FRCPath, DPhil, Alistair FRCPath, DipRCPath, Stephen MRCP, FRCR, Nita MBBS (Hons), FACD, PhD, E. Mary MD, FRCP, Fiona MRCP, MD, Julia FRCP, Michael BSc (Hons), Sean MD, FRCP,